Karina Negron

Title: Karina Negron: Innovator in Drug Delivery Systems

Introduction

Karina Negron is a prominent inventor based in Baltimore, MD (US). She has made significant contributions to the field of drug delivery, particularly in developing innovative nanoparticles for brain treatment. Her work focuses on enhancing therapeutic distribution within the central nervous system (CNS).

Latest Patents

Karina Negron holds a patent for "Nanoparticles for drug delivery to brain." This invention describes non-adhesive brain-permeable nanoparticles, as large as 200 nm, that can diffuse rapidly in the brain extracellular space. These nanoparticles are made entirely of generally recognized as safe (GRAS) materials and possess a neutral surface charge. The synergistic improvement of therapeutic distribution enabled by these nanoparticles, along with osmosis-driven brain extracellular matrix (ECM) modulation, significantly enhances drug and gene delivery within the CNS. This innovation offers a higher drug payload, improved drug loading efficiency, and significantly longer drug release durations.

Career Highlights

Karina Negron is affiliated with Johns Hopkins University, where she continues her research and development in drug delivery systems. Her work has garnered attention for its potential to revolutionize treatment methods for various neurological conditions.

Collaborations

Some of her notable coworkers include Jung Soo Suk and Justin Scot Hanes, who contribute to her research efforts and innovations in the field.

Conclusion

Karina Negron's work in developing nanoparticles for drug delivery represents a significant advancement in medical technology. Her contributions are poised to enhance treatment options for patients with neurological disorders, showcasing the importance of innovation in healthcare.